The core allegations involve the Meta Pixel, a tracking tool the plaintiffs say Eyemart installed on its website. According to the complaint, the pixel transmitted information about users' searches, clicks, product views, purchases, and appointment scheduling to Meta, and the plaintiffs argue that this data was tied to their identities. Because all five named plaintiffs had Facebook accounts, the plaintiffs contend Meta could match the browsing data to them. The case is one of many. Plaintiffs have filed a large number of class actions nationwide alleging that Meta Pixel, Google Analytics, and similar software on defendants' websites secretly captured web-browsing data. Meta has also faced setbacks elsewhere. On March 30, 2026, a federal judge in California denied class certification in a data-privacy class action over third-party websites' use of Meta's free Pixel code. Meta's SEC filings separately disclose individual and class actions in Europe and Canada and regulatory investigations in the United States, Europe, and elsewhere tied to its business tools.
The ruling strengthens plaintiffs' position at the pleading stage. The Fifth Circuit joins other federal appellate courts that have recognized standing based on alleged unauthorized disclosure of identifiable online viewing, browsing, or purchasing activity. The opinion is narrow, however. It does not hold that every interaction with a health-related website is IIHI, or that every use of the Meta Pixel violates privacy law, and the merits remain undecided. Commentators expect the decision to shape litigation over tracking technologies on websites offering health-related products or services, and it adds to the case law plaintiffs' lawyers can cite in similar suits. Attorneys defending health-adjacent retailers should review their pixel deployments and watch how the Northern District of Texas handles remand.